Horizon Therapeutics plc Announces TEPEZZA® (teprotumumab-trbw) Selected as a Winner of the Chicago Innovation Award
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics today announced that TEPEZZA® (teprotumumab-trbw) has been selected as a winner of the 19th Annual Chicago Innovation Award